U.S. News & World Report Rankings
At the Forefront of Medicine
The University of Chicago Medicine has continued to improve in U.S. News & World Report’s annual survey of the country’s best hospitals. Ten adult specialties were recognized as being among the best in the country in the 2024-25 annual U.S. News and World Report rankings.
The ten specialties include cancer (#12), cardiology and heart surgery (#32), diabetes and endocrinology (#30), ear, nose and throat (#11), gastroenterology and GI surgery (#25), geriatrics (#40), neurology and neurosurgery (#36), OB-gynecology (#25), pulmonology and lung surgery (#35) and urology (#36).
Sixteen high-performing procedures or conditions were also ranked: Aortic Valve Surgery; Colon Cancer Surgery; COPD, Diabetes; Gynecological cancer surgery; Heart Attack; Heart Bypass Surgery, Heart Failure, Hip Fracture; Kidney Failure; Leukemia, Lymphoma and Myeloma; Lung Cancer Surgery, Pneumonia; Prostate Cancer Surgery, Stroke; and Transcatheter aortic valve replacement (TAVR).
2024 Milestones
UChicago Medicine faculty advance the forefront of health every day by bringing research to reality and advanced care closer to our patients. Below is a selection of notable highlights from 2024:
- Raghavendra Mirmira, MD, PhD, and colleagues identified PERK inhibition as a potential strategy to prevent or delay the development of Type 1 diabetes in The Journal of Clinical Investigation.
- Samuel Refetoff, MD, and colleagues identified a novel form of TSH resistance caused by mutations in a thyroid-specific enhancer that increases expression of microRNAs linked to TSH regulation in Nature Genetics.
- Louis Philipson, MD, PhD, obtained funding as a member of the steering committee of the Precision Medicine in Diabetes international initiative that developed a series of 14 systematic reviews with over 20 authors regarding opportunities created by applying the concepts of precision medicine to diabetes. See “Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine” in Nature Medicine.
- Brian Kim, MD, an expert in the clinical management of thyroid disorders, was recruited to the University of Chicago as Associate Professor of Medicine.
- Margo Emont, PhD, an expert on adipocyte subpopulations and their functional consequences, was recruited to the University of Chicago as Assistant Professor of Medicine.
- With the leadership of David T. Rubin, MD, the Section of Gastroenterology, Hepatology and Nutrition continued to enjoy success and growth in education, research, innovation, and clinical programs last year. Thanks to peer recommendations from medical professionals like you, Newsweek ranked our program one of the World’s Best Specialized Hospitals.
- The Section welcomed two new faculty in 2023.
- Tenzin Choden, MD, Assistant Professor of Medicine, specializes in inflammatory bowel disease (IBD), with clinical interests in ulcerative colitis, Crohn’s disease, and checkpoint inhibitor colitis. Her primary research interests involve studying various aspects of the care of older patients with IBD, such as frailty, medication management and cancer surveillance. She serves on the Training Committee of the American College of Gastroenterology.
- Lalitha Sitaraman, MD, Assistant Professor of Medicine, specializes in motility disorders of the intestines. This specialty studies the movement of the intestinal muscles and ways to better characterize and study how the bowel functions.
- In 2023, the Section grew clinical programs both on campus and at off-site locations. Multiple GI faculty members perform endoscopies at the UChicago Medicine River East location and will continue to grow procedure volumes at other satellite locations, including a new site in Northbrook and expansions in Hinsdale and Northwest Indiana.
- Last year, the Section research portfolio again exceeded $17M and included two NIH R01 grants from Eugene B. Chang, MD, an NIH RC2 grant from Bana Jabri, MD, PhD, and a NIH R01 grant from Cambrian Liu, PhD, on colonic epithelial wound healing by transitional anal cells. Additionally, Eugene B. Chang, MD, and Edwin K. McDonald IV, MD, received GI Research Foundation (GIRF) funding for community outreach on the impact of diet on gut microbial health and function. David T. Rubin, MD, received GIRF funding for assessing the bidirectional impact of GI inflammation and mental health on patients with IBD. Cambrian Liu, PhD, received GIRF funding for reprogramming stem cells to treat IBD.
- The fiscal year 2023 GI Fellowship Program, under the leadership by Andrew Aronsohn, MD, includes 12 categorical fellows, four of whom are part of the Department’s Physician Scientist Development Program. Over half of our fellows are women, and over a quarter of our fellows are underrepresented in medicine. The Section has six advanced fellows in interventional endoscopy, inflammatory bowel disease, transplant hepatology, and nutrition, with a visiting advanced fellow in GI cancer.
- The Section has expanded the community engagement program co-led by Edwin K. McDonald IV, MD, and Sonali Paul, MD, MS, that focuses on diet, cooking, and nutrition education. Over the summer, Dr. McDonald led a high school internship program with two interns who worked in the GI Section. They primarily shadowed Dr. McDonald in clinic and during procedures and had the opportunity to shadow his colleagues in interventional GI, IBD, hepatology, and general surgery. Dr. McDonald also partnered with the Association of Black Gastroenterologists and Hepatologists and local comedians for a community outreach event geared towards educating the South Side Chicago community about gastrointestinal diseases. The program took place before 300 people in The Promontory in Hyde Park and won a coveted SCOPY Award for education from the American College of Gastroenterology.
Additional Highlights and Accomplishments:
- Eugene B. Chang, MD – Recipient of the Walter Palmer Senior Alumni Award; Gastrointestinal Research Foundation (2023)
- Uzma Siddiqui, MD – Recipient of a 2023 Crystal Award: Master Endoscopist Award
- Valerie Abadie, PhD – Recipient of the Celiac Disease Foundation Young Investigator Prize in Basic Science (2023)
- Sonali Paul, MD, MS – Recipient of the Joseph B. Kirsner Mentorship Award (2023)
- David T. Rubin, MD – Recipient of the 2023 Department’s Arthur H. Rubenstein Mentorship in Academic Medicine Award
- Sonia Kupfer, MD – Appointed Associate Vice Chair for Research
- Sonali Paul, MD, MS – Appointed Associate Program Director, Internal Medicine Residency Program and Faculty Advisory Committee Member, Patient Care and Training
2023 Select High Impact Publications
- Dolinger MT, Krugliak Cleveland N, Rubin DT, Dubinsky MC. Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States. Am J Gastroenterol. 2023
- Akhlaghpour M, Haritunians T, More SK, Thomas LS, Stamps DT, Dube S, Li D, Yang S, Landers CJ, Mengesha E, Hamade H, Murali R, Potdar AA, Wolf AJ, Botwin GJ, Khrom M; International IBD Genetics Consortium; Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Sartor RB, Xavier RJ, Brant SR, Cho JH, Duerr RH, Lazarev MG, Rioux JD, Schumm LP, Silverberg MS, Zaghiyan K, Fleshner P, Melmed GY, Vasiliauskas EA, Ha C, Rabizadeh S, Syal G, Bonthala NN, Ziring DA, Targan SR, Long MD, McGovern DPB, Michelsen KS. Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut. 2023
- Siddiqui UD. Top tips for colonic EMR (with video). Gastrointest Endosc. 2023
- Goldowsky A, Ding J, Vélez C, Paul S. Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology. Gastroenterology. 2023
- Kastrinos F, Kupfer SS, Gupta S. Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology. 2023
- Duong N, Lee TH, Newman KL, Goldowsky A, Jencks KJ, Chedid V, Barrow J, Burbridge R, Chiang A, Targownik L, Simonetto DA, Paul S. Overcoming disparities for sexual and gender minority patients and providers in gastroenterology and hepatology: introduction to Rainbows in Gastro. Lancet Gastroenterol Hepatol. 2023
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023
- Allocca M, Kucharzik T, Rubin DT. Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is It Ready for Standard Practice? Gastroenterology. 2023
- Katherine Thompson, MD, received a $5 million competitive grant renewal for the Geriatric Workforce Enhancement Program, “Sharing Healthy Aging Resources and Education.”
- Megan Huisingh-Scheetz, MD, MPH, received the 2024 Terrie Fox Wetle Rising Star Award in Health Services and Aging Research. Presented by the American Federation for Aging Research, the honor recognizes an influential clinician in an early or middle phase of their career who is likely to shape practice and research for decades to come.
- Heather Leeper, MD, named a Bucksbaum Institute for Clinical Excellence Junior Faculty Scholar, developed a serious illness communication curriculum for neurology trainees.
- Stacie Levine, MD, and Andrea J. Landi, MD, published qualitative outcomes on nursing home residents’ experiences with substance use disorders in the Journal of Addiction Medicine.
- Lauren Gleason, MD, MPH, appointed the inaugural Medical Director of Post-Acute Care, will lead age-friendly initiatives across the health system.
- Largest Transplant Program in the Midwest: Our program continues to lead the region, delivering exceptional outcomes and unmatched expertise in organ transplantation.
- Largest Multi-Organ Transplant Program: Demonstrating our multidisciplinary approach, we excel in providing complex, multi-organ transplant care with outstanding success rates.
- Participation in Advanced Mechanical Circulatory Support Clinical Trials: We are proud to contribute to leading-edge research through participation in the BrioVAD and BiVACOR trials, advancing mechanical circulatory support technology and patient care.
- Nation's Largest Bloodless Medicine and Heart Surgery Program: By offering bloodless heart surgery (transfusion-free procedures), we perform lifesaving surgery without compromising our patients’ religious or personal reasons for needing “blood-free” care and treatment.
- Now Offering Pulsed Field Ablation: This state-of-the-art treatment at UChicago Medicine address atrial fibrillation, enhancing patient outcomes with precision and safety.
- Renal Denervation for Resistant Hypertension: Our specialists offer this groundbreaking procedure to patients with persistent hypertension despite traditional therapies.
- Deep Vein Arterialization for Limb Salvage: This unique procedure provides a new option for patients with critical limb ischemia, preserving mobility and improving quality of life.
- Innovative Thoracoabdominal Aortic Aneurysm Endovascular Device: Our team utilizes a new thoracoabdominal aortic aneurysm endovascular device to treat complex aneurysms, enabling less invasive solutions for high-risk cases.
Peter Warnke, MD, and the epilepsy team achieved a major milestone using laser ablation to treat a patient with Sturge-Weber syndrome, leaving them seizure-free with no deficits. Additionally, Dr. Warnke performed his 50th laser capsulotomy for refractory obsessive-compulsive disorder, solidifying our program as the largest worldwide for this groundbreaking treatment. These advancements provide renewed hope for patients facing complex neurological challenges.
Innovative Modeling and Therapeutic Discovery for Neuropathies
R. Grace Zhai, PhD, and her team pioneered the use of Drosophila genetic model systems to understand human neuropathies. They have successfully modeled SORD peripheral neuropathy, a CMT2-like neuropathy caused by a deficiency in sorbitol dehydrogenase. Their mechanistic study and therapeutic discoveries have led to an innovative therapeutic drug that is currently in phase 3 clinical study for SORD neuropathy.
NIH Grant for Gut Microbiome Impacts on Brain Disease
The lab of Sean Polster, MD, was awarded the NIH NRCDP K Grant, bringing funding to nearly half a million dollars. Supported by the American College of Surgeons and the North American Skull Base Society, their research investigates the gut-brain axis and the effects of SRS on the neurovascular unit, with implications for brain disease and the blood-brain barrier.
The team led by Tao Xie, MD, PhD, was awarded an NIH U01 award totaling $3.44 million to carry out a cross-sectional and longitudinal study of gut microbiota in Parkinson’s disease (PD). This interdisciplinary study will identify dysbiosis and microbiota metabolomics as markers of PD phenotypes, predictive of the development and progression of PD and PD subtypes, and potential targets for disease-modifying therapies.
Research on mTOR Inhibitor Drug in CCM
Issam Awad, MD, and his team, in collaboration with Duke University, published a study in Translational Stroke Research highlighting mixed effects of rapamycin on familial cerebral cavernous malformations (CCM). This research identified both potential benefits and risks, underscoring the need for further exploration of selective patient treatment approaches.
Advancing Neurotrauma Care Through Collaboration
Paramita Das, MD, MS, Fernando Goldenberg, MD, Christos Lazaridis, MD, Ali Mansour, MD, Susan Rowell, MD, MBA, and the neurotrauma team at UChicago Medicine hosted a groundbreaking symposium dedicated to advancing the care of patients with brain and spine injuries. This event gathered leading experts in neurotrauma, fostering collaboration and sharing innovative approaches to improve outcomes for patients facing critical injuries. Such initiatives underscore the team's commitment to leadership in neurotrauma research and education.
Research Advancements in Malignant Glioma
Bakhtiar Yamini, MD, and his research team made significant strides in brain tumor therapeutics this year. Their multi-institutional, phase 1 study, led by the UChicago team, explored the combined use of acetazolamide and temozolomide in adults with newly diagnosed MGMT-methylated malignant gliomas, providing promising insights into optimizing treatment approaches for these challenging tumors.
The Margaret Hackett Family Program
The program had a productive year in clinical research, with a study on Chiari I malformation accepted by Neurosurgery and numerous presentations at top conferences, including the Congress of Neurological Surgeons 2024. The team's work spanned achondroplasia, Klippel-Feil Syndrome, and advanced neuroimaging, further solidifying its leadership in pediatric neurosurgery research.
Neurotrauma Training Program for Military Providers
Through a multiple PI grant, funded by the Medical Technology Enterprise Consortium, the University of Chicago will establish a comprehensive Neurotrauma Training Program to enhance wartime readiness. The program builds on existing Military-Civilian Partnerships and leverages UChicago’s high volume of neurotrauma cases to train non-neurosurgeons in managing penetrating traumatic brain injuries (pTBI). The initiative also includes creating a robust data commons and pTBI biorepository to facilitate evidence-based treatment, rapid diagnosis and research advancements.
Publications and Presentations
UChicago neurology faculty members authored more than 110 publications and made more than 60 presentations, making significant impact in the areas of aging, Alzheimer’s disease, aphasia, ataxia, epilepsy, hospital care, multiple sclerosis, neuromuscular diseases, Parkinson’s disease, stroke, and traumatic brain injury.
Grants, Funding and Science Innovation
Neurology faculty received 46 research grants with a total of $12.6 million from external funding agencies in 2024. Many are multi-year projects with total awards of $55.5 million. Our neurology faculty also filed two patent applications in 2024.
- Five decades after our original National Cancer Institute (NCI) designation, the NCI renewed our status as a "Comprehensive Cancer Center." The prestigious designation recognizes us as one of the nation's top research and treatment facilities.
- We opened a 130,000-square-foot multispecialty care center to serve patients in Northwest Indiana. Our Crown Point facility brings the total number of locations offering cancer services throughout our network to 20.
- Two large gifts from the AbbVie Foundation and Susan and Tandean Rustandy will help support the construction of our new cancer pavilion, the first freestanding facility in Illinois dedicated to reshaping cancer care.
- We led a number of practice-changing clinical trials that defined new standards of care, including a less aggressive approach to lung cancer surgery pioneered by Everett Vokes, MD, and an immunotherapy and chemotherapy combination treatment for lung cancer that increased survival led by Marina Garassino, MD.
- A joint project with Argonne National Laboratory will use leading-edge AI technology to mine vast datasets and uncover patterns that can lead to the development of new treatments for drug-resistant cancer.
- We launched the Center to Eliminate Cancer Inequity, a new research hub bringing together researchers, healthcare providers and community members to eliminate Chicago’s chronic cancer disparities.
- We celebrated 10 years of exceptional research training programs for high school students, college students, and middle and high school science educators. NCI Director W. Kimryn Rathmell, MD, PhD, MMHC, and U.S. Senator Dick Durbin (D-IL) gave presentations on our campus for the occasion.
- We became one of the few centers in the nation to offer tumor-infiltrating lymphocytes (TIL) therapy, an innovative new cancer treatment for patients with advanced melanoma.
- Jennifer Wolf, MD, PhD, was named Chair of the Department of Orthopaedic Surgery. Dr. Wolf has been awarded more than $2.5 million in grant funding, has published more than 140 peer-reviewed articles, and is past president of the American Society for Surgery of the Hand.
- Led by Tessa Balach, MD, the department has become a high-enrolling site for an NIH-funded trial investigating pain after total knee arthroplasty.
- Lewis L. Shi, MD, in the Division of Shoulder and Elbow Surgery, co-authored “Active biointegrated living electronics for managing inflammation,” published In Science. The study discusses how a combination of live cells, gel and electronics can heal soft tissues.
- OrthoReach, our outreach program for at-risk high school students, has received grant funding from the American Academy of Orthopaedic Surgeons to expand our activities.
- Our sports medicine and orthopaedic surgeons proudly serve as the official physicians for WNBA's Chicago Sky.
- Eight OHNS faculty members, Nishant Agrawal, MD, Elizabeth Blair, MD, Michael Gluth, MD, Jayant Pinto, MD, Louis de Guzman Portugal, MD, Andrea Shogan, MD, Fuad Baroody, MD, and Dana Suskind, MD, were named to Chicago Magazine’s Top Doctors list.
- Dana Suskind, MD, received funding from the Bill & Melinda Gates Foundation, the Connecticut Office of Early Childhood, and the Frechette Family Foundation, among others, to support the TMW Center for Early Learning + Public Health. The mission of the TMW Center is to create a national shift in the knowledge and behavior of parents and caregivers that leads to optimal foundational brain development in all children during the first five years of life.
- Nishant Agrawal, MD, was awarded funding from the NCI to study “Multi-analyte Approach for Earlier Detection of Cancer in Non-Plasma Biofluids.” This project aims to develop noninvasive, biofluid-based "liquid biopsy" assays using saliva and other biofluids for the early detection of cancers, including head and neck cancers, addressing current limitations in minimally invasive cancer diagnostics.
- Elizabeth Blair, MD, Dana Suskind, MD, and Andrea Shogan, MD, were listed in the Castle Connolly 2024 List of Exceptional Women in Medicine. The list recognizes women who have demonstrated outstanding leadership, expertise and dedication in their respective fields.
- Jayant Pinto, MD, was awarded the top #HeForShe Award at the Women in Medicine Summit.
- Jayant Pinto, MD, was also featured in the American Academy of Otolaryngology-Head and Neck Surgery Journal for his publication, "A Social Media Quality Review of Popular Sinusitis Videos on TikTok." This article aimed to assess the quality of sinusitis-related videos on TikTok.
- Brandon Baird, MD, was interviewed on “TODAY,” a popular morning show and online platform covering news, wellness, parenting, pop culture, and more, to discuss gender-affirming voice therapy. The article explores the transformative impact of gender-affirming voice therapy, highlighting Dr. Baird's expertise as he supports individuals in aligning their voices with their gender identities, emphasizing the therapy's significance for mental health and self-expression.
- Brandon Baird, MD, was also featured on “Tamron Hall” and “ABC- Channel 7 Eyewitness News," discussing the career-saving surgery he performed on news anchor Samantha Chatman.
- The University of Chicago Section of Otolaryngology-Head and Neck Surgery hosted the 7th Head and Neck Cancer Symposium. This national three-day course, led by Nishant Agrawal, MD, and Ellen MacCracken, MS, featured experts who addressed challenges facing practitioners who treat patients with head and neck cancers.
- In Spring 2024, UChicago Otolaryngology-Head & Neck Surgery expanded its services to UChicago Medicine’s newest facility in Crown Point, Indiana, where we provide area residents with subspecialty care in head and neck cancer, otology and pediatric otolaryngology. The new Crown Point micro-hospital was named winner of the 2024 International Interior Design Association Healthcare Design Award, which honors innovation and excellence in the design and furnishings of healthcare spaces.
- Our Interventional Pulmonary (IP) program continues to be the largest in the Chicago area. Septimiu Murgu, MD, D. Kyle Hogarth, MD, and Ajay Wagh, MD, MS, provide state-of-the-art diagnostic approaches and treatments to our patients.
- We are the leading center for bronchoscopic lung volume reduction (endobronchial valves), airway stenting, robotic bronchoscopy, bronchoscopic ablation of airway tumors, and management of tracheal stenosis and tracheobronchomalacia.
- We are part of the multi-disciplinary Complex Airway Center to manage laryngo-tracheal diseases in conjunction with colleagues from otolaryngology and thoracic surgery.
- Dr. Murgu is the current President of the American Association for Bronchology and Interventional Pulmonology and the recipient of CHEST 2023 Edward C. Rosenow III, MD, Master FCCP/Master Teacher Endowed Honor Lecture.
- Dr. Hogarth was named as a top doctor and spotlighted in Chicago Magazine.
- Our Sleep Center, directed by, Esra Tasali, MD, Hyde Park location’s American Academy of Sleep Medicine (AASM) Accreditation was obtained on April 4, 2023, maintaining 40 years of continuous accreditation and one of the oldest centers in the country.
- Alejandra Lastra, MD, was appointed as the Chair of the AASM Education Committee, which develops educational programs, initiatives, and products for sleep physicians as well as patients with sleep disorders. She also founded the inpatient advanced respiratory care consult service.
- Phillip LoSavio, MD, was appointed as the new Chair of the Education Committee for the International Sleep Surgery Society (ISSS). He will be leading the ISSS global education strategy for attendings and residents.
- Gorav Sharma, MD, joined as an Assistant Professor and Associate Program Director for the Sleep Medicine Fellowship effective August 1, 2023.
- Our Interstitial Lung Disease (ILD) program, directed by Mary E. Strek, MD, is among one of three Pulmonary Fibrosis Foundation Care Centers in Illinois. Other ILD specialists include Cathryn Lee, MD, and Ayodeji Adegunsoye, MD, who also directs post-COVID pulmonary clinic.
- Our COPD program led by Lucas Kimmig, MD, provides inpatient and outpatient care through a dedicated team of advanced practice providers. We have successfully reduced readmission rates via this comprehensive program. We also partner with our sleep medicine team to streamline the facilitation for home non-invasive ventilator support.
- Our Cystic Fibrosis (CF) Program is led by Edward T. Naureckas, MD, together with Kevin Tsui, MD, as Associate Adult Program Director. This program provides multidisciplinary care including pharmacy, nutrition, behavioral health respiratory therapy and physical therapy evaluation to improve the lives of adults with CF and bronchiectasis.
Expanded access to our specialists across the region
- The Northbrook location, UCM’s first site on Chicago’s North Shore, offers urogynecology and reconstructive pelvic surgery, minimally invasive surgery for endometriosis, and obesity medicine-gynecology.
- The new UCM Crown Point location offers gynecologic oncology, urogynecology, and minimally invasive surgery.
Leading in gynecologic surgery
- Urogynecology and Reconstructive Pelvic Surgery Chief Kimberly Kenton, MD, MS, and Gynecology Quality Chief Margaret Mueller, MD, published a review of Activity Restrictions After Gynecologic Surgery in Obstetrics & Gynecology. Their report challenges traditional postoperative restrictions and advocates for increased activity to support recovery.
Contributions to cancer research
- We’re addressing inequities in cancer with UCM’s new AbbVie Foundation Cancer Pavilion set to open on our Hyde Park campus in 2027.
- UCM received the highest honor from the National Cancer Institute, our designation as one of only 56 comprehensive cancer centers nationwide and one of two in Illinois.
- U.S. News & World Report's 2024-2025 rankings listed UCM as the top cancer hospital in Illinois and ranked us as “high performing” for gynecological cancer surgery.
- Our commitment to advancing cancer biology is reflected in multiple articles in leading journals and honors, including:
- Adipocytes promote metastasis by diverting glucose by Ernst Lengyel, MD, PhD, in Nature Metabolism
- The burden of cervical cancer survivorship by Sarah Ackroyd, MD, MPH, in Gynecologic Oncology Reports
- A National Institutes of Health grant awarded to Katherine Kurnit, MD, MPH, to study molecular classification and targeted tumor therapy for endometrial cancer.
- Our gynecologic oncology team, the largest in the Midwest, expanded with the addition of Sudarshan Sharma, MD, at UCM AdventHealth Hinsdale.
Transforming obstetrics through innovation and patient-centered care
- Under the leadership of Sarosh Rana, MD, MPH, UCM’s inaugural Chief Obstetric Transformation Officer, we are focused on addressing disparities in care for patients with hypertensive disorders of pregnancy and pioneering biomarker testing. We have since earned a Citation of Merit from the American Hospital Association (July 2023) and the Bernard J. Tyson National Award for Excellence in Pursuit of Healthcare Equity (October 2023).
- While many hospitals chose to discontinue midwifery services, UCM added midwifery to meet patients’ desires for a more personalized birth experience.
- Led by Mahmoud Khalil, MBBCh, Assistant Professor of Surgery, UChicago Medicine Ingalls Memorial Hospital is among the first in the area to offer Aquablation therapy, the real-time, ultrasound-guided, robotic-assisted, heat-free waterjet for the treatment of Benign Prostatic Hyperplasia (BPH).
- Led by Abhinav Sidana, MBBS, MPH, Director of Focal Therapy for prostate cancer (CaP), we now offer five modalities to target localized prostate cancer and spare healthy tissue. Dr Sidana received a grant for evaluating PSMA-PET in surveillance after focal therapy. He also led a master class on Rectal Spacer placement and on Genetic Testing in Prostate Cancer Management while leading FOCAL+ 2024 a national CaP conference in San Diego.
- Our CaP program is a national leader in treating patients, managing one of the largest volumes of cases in the country.
- Gregory Bales, MD, Clinical Associate of Surgery, rejoined Sarah Faris, MD, Associate Professor of Surgery, and Ervin Kocjancic, MD, Professor of Surgery, to augment our urologic reconstruction, gender affirmation and female urology program.
Best Hospitals and Medical Schools Rankings
See full rankings and methodology for all U.S. News & World Report.